Successful Treatment of Persistent SARS-CoV-2 Infection in an Immunocompromised Patient

Posted 2 years ago

More about Jacobson Research Group

Recent Publications

Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk October 31, 2024 Pamela M Murnane
Understanding the impact of pandemics on long-term medication adherence: directly observed therapy in a tuberculosis treatment cohort pre- and post-COVID-19 lockdowns October 13, 2024 Victoria Overbeck
Evaluation of the Tuberculosis Infection Care Cascade Among Pregnant Individuals in a Low-Tuberculosis-Burden Setting September 6, 2024 Jeffrey I Campbell
Percent of lung involved in disease on chest X-ray predicts unfavorable treatment outcome in pulmonary tuberculosis September 4, 2024 Marwan Ghanem
Patient and provider perceptions of the relationship between alcohol use and TB and readiness for treatment: a qualitative study in South Africa August 14, 2024 Suchitra Kulkarni
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs July 10, 2024 Marie Wijk
For Tuberculosis, Not "To Screen or Not to Screen?" but "Who?" and "How?" April 18, 2024 Maha Reda Farhat
Analysis of the limited <em>M. tuberculosis</em> accessory genome reveals potential pitfalls of pan-genome analysis approaches April 8, 2024 Maximillian G Marin
Tuberculosis testing patterns in South Africa to identify groups that would benefit from increased investigation November 27, 2023 Anne N Shapiro
Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIF October 28, 2023 Lesley Erica Scott

Tweets by kar_jacobson